In addition, the upregulation of GATA2 is associated with chemoresistance in the prostate cancer cell lines DU145 and 22Rv1, and GATA2 expression is likewise highest in CRPC patients treated with chemotherapy (47). This evidence concerns the gene GATA2 and prostate carcinoma.